D-0563-2025 Class II Ongoing

Recalled by AEQUITA PHARMACY — Kirkland, WA

FDA drug recall D-0563-2025 was initiated by AEQUITA PHARMACY on Jul 18, 2025 and is designated Class II. Reason for recall: Lack of Processing Controls. The recall status is ongoing. Affected quantity: 190 vials.

Recall details

Product Type
Drugs
Report Date
Aug 13, 2025
Initiation Date
Jul 18, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
190 vials

Product description

Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

Reason for recall

Lack of Processing Controls.

Distribution pattern

MA

Code information

All Lots within expiry.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0563-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0563-2025. Report a data issue: hello@regdatalab.com.